Scientists for Future

Under the motto "Fridays for Future" jung people all around the world campaign for a more vigorous fight against climate change. Likewise, in many German towns pupils and students came out on strike every Friday in order to publicly call attention to their cause.

We at CliPS think that this commitment is admirable und we are delighted to see that numerous scientists have meanwhile gathered under the name of "Scientists for Future" in order to support the pupils and students with scientific arguments. Our own professional discipline - clinical research - is home to countless scientists, many of whom have surely already contemplated the topic of climate change. We would like to ask all our colleagues to catch up on "Fridays for Future" and "Scientists for Future". If you speak German, please watch the video "Aufruf an die Politik" (call on politicians).

We have decided to sign the statment issued by "Scientists for Future" and we would be glad if as many colleagues from our branch of industry as possible could do the same.

Appointment to the GQMA Board

The German Quality Management Association e.V. (GQMA) is the largest German specialist society for quality management in the chemical and pharmaceutical industry. The GQMA's activities include annual conferences, various working parties, advanced training courses, and the cooperation with other German and European expert associations. Together with the German Society for Pharmaceutical Medicine (DGPharMed) the GQMA publishes "PM QM" - the Journal for Pharmaceutical Medicine and Quality Management.

Our experts at CliPS - Clinical Project Services® are members of the GQMA. Most of them have, for instance, been actively involved in the working party "GCP - Clinical Operations" for many years.

We at CliPS are delighted to inform you that on its meeting of 25 April 2019 the Board of the GQMA has decided to appoint Dr. Ingo Rath to the Extended Board. As the GQMA's representative in the "PM QM" editorial committee Ingo will help ensuring that the results of the GQMA's activities as well as current topics, discussions and insights from the field of chemical and pharmaceutical industry are being brought to the attention of a wider expert audience.

To find out more about the GQMA, please click here.


CliPS welcomes Dr. Viktoria Pavel

We are delighted to announce that Dr. Viktoria Pavel has joined our team at CliPS - Clinical Project Services® on 1st January, 2019.

During her 13 years in the field of clinical research Viktoria mainly worked as project manager in clinical trials but also gained experience in clinical monitoring, medical writing, and the management of a professional investigational trial site. Working at CROs she has been in charge of studies for a wide spectrum of sponsors in various therapeutic areas and she is particularly familiar with applications to ethics committees and regulatory authorities.

Victoria already convinced us of the excellent quality of her work during a recent freelance colaboration.
We now warmly welcome her as a full member of the CliPS team and are very happy that she supports us and our clients with her substantial expertise.

New Recommendations for GCP Trainings

Sorry, this page is not available in English.

The German page addresses new recommendations to German Ethics Committees assessing the qualification of investigators in clinical trials.

A publication by Dr. Christoph Ortland of Forschungsdock GmbH and Dr. Ingo Rath of CliPS in the journal PM/QM is available in German here.

If you want to learn more about current recommendations for GCP trainings for German investigators, please contact us.


News from BfArM and PEI

Neues von BfArM und PEIThe Federal Institute for Drugs and Medical Devices (BfArM) and the Paul-Ehrlich-Institute (PEI) jointly publish a quarterly drug safety bulletin called

"Bulletin zur Arzneimittelsicherheit".


You can find the current edition using this link.

Further news from the higher federal authorities:

Read More: News from BfArM and PEI
This website uses cookies. By using this site, you agree to our use of cookies.
Read more